Ginkgo Bioworks Holdings, Inc.
DNANYSECIK 1830214HealthcareFiscal year ends Dec 31
Reports and events: 120 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0616:09 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-054298 |
| 2026-08-0516:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-053319 |
| 2026-07-3016:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-051041 |
| 2026-06-1217:00 ET | 8-K | 5.07 Shareholder vote results | 0001628280-26-042932 |
| 2026-05-0716:13 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-032116 |
| 2026-05-0716:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-032093 |
| 2026-04-2916:10 ET | DEF 14A | Proxy statementPeriod 2026-06-11 | 0001628280-26-028377 |
| 2026-04-0717:02 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001628280-26-024101 |
| 2026-02-2721:56 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-26-012552 |
| 2026-02-2616:34 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-012346 |
| 2026-02-2616:30 ET | 8-K | 2.02 Results of operations | 0001628280-26-012339 |
| 2025-12-2317:26 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events | 0001628280-25-058791 |
| 2025-11-0616:17 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-050193 |
| 2025-11-0616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001830214-25-000013 |
| 2025-09-0416:57 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001830214-25-000009 |
| 2025-08-2916:07 ET | 8-K | 8.01 Other events | 0001628280-25-041399 |
| 2025-08-0717:05 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-038982 |
| 2025-08-0717:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-038981 |
| 2025-06-1316:06 ET | 8-K | 5.07 Shareholder vote results | 0001628280-25-031304 |
| 2025-05-2116:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-027058 |
| 2025-05-0617:04 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-022761 |
| 2025-05-0617:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-022759 |
| 2025-04-2916:01 ET | DEF 14A | Proxy statementPeriod 2025-06-12 | 0001628280-25-020648 |
| 2025-02-2517:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-007819 |
| 2025-02-2517:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-007816 |
| 2025-02-1416:03 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001628280-25-005686 |
| 2024-11-1217:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-047284 |
| 2024-11-1217:03 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-24-047276 |
| 2024-09-0416:42 ET | 8-K | 3.01 Delisting notice; 8.01 Other events | 0001628280-24-039341 |
| 2024-08-1916:06 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001628280-24-037685 |
| 2024-08-1516:04 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001628280-24-037384 |
| 2024-08-0817:06 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-036231 |
| 2024-08-0817:03 ET | 8-K/A | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001628280-24-036226 |
| 2024-07-0517:18 ET | DEF 14A | Proxy statementPeriod 2024-08-14 | 0001628280-24-031299 |
| 2024-06-2417:16 ET | 8-K/A | 2.05 Exit or disposal costs | 0001628280-24-029635 |
| 2024-06-1416:07 ET | 8-K | 5.07 Shareholder vote results | 0001628280-24-028287 |
| 2024-05-1316:14 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-022896 |
| 2024-05-0916:11 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-022229 |
| 2024-05-0916:02 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001628280-24-022191 |
| 2024-04-2916:01 ET | DEF 14A | Proxy statementPeriod 2024-06-13 | 0001628280-24-018970 |
| 2024-03-1416:07 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001628280-24-011216 |
| 2024-02-2917:07 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001628280-24-008052 |
| 2024-02-2917:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-008045 |
| 2024-02-1417:05 ET | SC 13D/A | Ownership report, active investor, amended | 0001628280-24-004834 |
| 2024-02-1417:03 ET | SC 13D/A | Ownership report, active investor, amended | 0001628280-24-004831 |
| 2024-01-1007:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-001000 |
| 2023-11-0817:06 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001628280-23-037927 |
| 2023-11-0817:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-037916 |
| 2023-10-2717:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-23-265256 |
| 2023-10-0306:55 ET | 8-K | 8.01 Other events | 0001628280-23-033551 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:07 ET. Listed shows no prices and gives no investment advice.